Skip to main content

Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.

Publication ,  Journal Article
Biggers, K; Scheinfeld, N
Published in: Curr Opin Investig Drugs
April 2008

Savient Pharmaceuticals Inc (formerly Bio-Technology General Corp), under license from Duke University, is developing pegloticase, PEG conjugates of uricase (urate oxidase), for the potential treatment of gout. The in-life portion of the phase III trials have been completed.

Duke Scholars

Published In

Curr Opin Investig Drugs

ISSN

1472-4472

Publication Date

April 2008

Volume

9

Issue

4

Start / End Page

422 / 429

Location

England

Related Subject Headings

  • Urate Oxidase
  • Treatment Outcome
  • Structure-Activity Relationship
  • Recombinant Proteins
  • Polyethylene Glycols
  • Pharmacology & Pharmacy
  • Patents as Topic
  • Molecular Structure
  • Injections, Intravenous
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Biggers, K., & Scheinfeld, N. (2008). Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout. Curr Opin Investig Drugs, 9(4), 422–429.
Biggers, Kristen, and Noah Scheinfeld. “Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.Curr Opin Investig Drugs 9, no. 4 (April 2008): 422–29.
Biggers K, Scheinfeld N. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout. Curr Opin Investig Drugs. 2008 Apr;9(4):422–9.
Biggers, Kristen, and Noah Scheinfeld. “Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.Curr Opin Investig Drugs, vol. 9, no. 4, Apr. 2008, pp. 422–29.
Biggers K, Scheinfeld N. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout. Curr Opin Investig Drugs. 2008 Apr;9(4):422–429.

Published In

Curr Opin Investig Drugs

ISSN

1472-4472

Publication Date

April 2008

Volume

9

Issue

4

Start / End Page

422 / 429

Location

England

Related Subject Headings

  • Urate Oxidase
  • Treatment Outcome
  • Structure-Activity Relationship
  • Recombinant Proteins
  • Polyethylene Glycols
  • Pharmacology & Pharmacy
  • Patents as Topic
  • Molecular Structure
  • Injections, Intravenous
  • Humans